Fact CheckerSign in

NCT02486562Recruiting

iConquerMS™ - A Patient-Powered Research Network for Multiple Sclerosis

Source: ClinicalTrials.gov · Last updated 27 Oct 2026

Brief summary (registry, in English)

iConquerMS™ is a research initiative developed by and for people with multiple sclerosis (MS) to contribute their health data and ideas to advance and accelerate research into MS. iConquerMS welcomes adults with MS and others interested in advancing MS research, children and teens with MS and their family members (via iConquerMS Kids \& Teens) and MS caregivers (via iConquerMS Caregivers) to participate.

Status (registry)
Recruiting
Study type
Observational
Enrollment
20000 (estimated)
First submitted
25 Jun 2015
Start date
Nov 2014
Primary completion date
Oct 2030
Lead sponsor
Accelerated Cure Project for Multiple Sclerosis
NCT number
NCT02486562

What you commit to

  • Study type: Observational
  • Planned participants: 20000
  • From Nov 2014 to the primary completion date, Oct 2030
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Unwilling or unable to provide informed consent.

Who the study is looking for

  • 21 years of age or older at the time of informed consent or under 21 with parental consent and participant assent.

Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Accelerated Cure Project
Coordinator of this site? Confirm its status
WalthamUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.